Home > A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer’s Disease
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer’s Disease
Manuscript Number:
18-0759R3
Author(s):
Daniel L. Alkon, Jeffrey Benison, David Crockford, Martin R. Farlow, Elaine Grenier, Richard E. Thompson, Alan J. Tuchman, Lee-Jen Wei, Susanne Wilke
